Back to Market Feed

ETHOSUXIMIDE 250 MG/5 ML SOLN

Ethosuximide
$0.0780per ML
Low Outlier

Strength

250 mg/5mL

NDC

59762235006

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

8/23/2023

Active Ingredients

ETHOSUXIMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA080258

On Market Since

2/21/2020

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-17.2%

5Y

-59.7%

All

-59.7%

Generic Alternatives

1 alternative • Same active ingredient

ETHOSUXIMIDE 250 MG/5 ML SOLN
Generic
59762235007•Mylan Pharmaceuticals Inc.
$0.0942
+21% more

Related Drugs

Same classification

GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0211
per EA